title: Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy.
authors.forename: N
authors.initials: N
authors.lastname: Kumarasamy
authors.forename: Snigdha
authors.initials: S
authors.lastname: Vallabhaneni
authors.forename: Anitha J
authors.initials: AJ
authors.lastname: Cecelia
authors.forename: Kenneth H
authors.initials: KH
authors.lastname: Mayer
authors.forename: Suniti
authors.initials: S
authors.lastname: Solomon
authors.forename: Charles C J
authors.initials: CC
authors.lastname: Carpenter
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Flanigan
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage*; D044966:Anti-Retroviral Agents / Q000008:administration & dosage; D000981:Antiprotozoal Agents / Q000008:administration & dosage; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D003622:Dapsone / Q000008:administration & dosage; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007194:India; D008297:Male; D010419:Pentamidine / Q000008:administration & dosage; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000276:immunology / Q000517:prevention & control*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage; D028761:Withholding Treatment
chemical_list: D000890:Anti-Infective Agents; D044966:Anti-Retroviral Agents; D000981:Antiprotozoal Agents; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003622:Dapsone